0.31
0.31 (0%)
As of Apr 17, 2025
Reshape Lifesciences Inc. [RSLS]
Source:
Company Overview
ReShape Lifesciences Inc. is a premier physician-led weight-loss solutions company, offering an integrated portfolio of proven products and services that manage and treat obesity and metabolic disease throughout the care continuum.
| Country | United States |
| Headquarters | san clemente, california |
| Phone Number | 949-429-6680 |
| Industry | manufacturing |
| CEO | Paul F. Hickey |
| Website | www.reshapelifesciences.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $8 |
| Operating Profit | $-7.7 |
| Net Income | $-7.1 |
| Net Cash | $-3.8 |
Profit Ratios
| Gross Margin | $5.1 |
| Operating Margin | -96.5 |
| Profit as % of Revenues | -70.9% |
| Profit as % of Assets | -92.3% |
| Profit as % of Stockholder Equity | 2,818.2% |
Management Effectiveness
| Return on Equity | 2,818.2% |
| Return on Assets | -148.8% |
| Turnover Ratio | 103.6% |
| EBITA | $-7.7 |
Balance Sheet and Cash Flow Measures
| Total Assets | $4.8 |
| Total Liabilities | $5 |
| Operating Cash Flow | $-4.4 |
| Investing Cash Flow | $0 |
| Financing Cash Flow | $0.7 |
